Does coexisting accommodative dysfunction impact clinical convergence measures, symptoms and treatment success for symptomatic convergence insufficiency in children?
- PMID: 36111644
- PMCID: PMC10578959
- DOI: 10.1111/opo.13052
Does coexisting accommodative dysfunction impact clinical convergence measures, symptoms and treatment success for symptomatic convergence insufficiency in children?
Erratum for
-
Does coexisting accommodative dysfunction impact clinical convergence measures, symptoms and treatment success for symptomatic convergence insufficiency in children?Ophthalmic Physiol Opt. 2022 Jan;42(1):59-70. doi: 10.1111/opo.12911. Epub 2021 Nov 3. Ophthalmic Physiol Opt. 2022. PMID: 34730250 Free PMC article.
References
-
- Kulp MT, Sinnott LT, Cotter SA, Borsting E, Toole AJ, Chen AM, et al. Does coexisting accommodative dysfunction impact clinical convergence measures, symptoms and treatment success for symptomatic convergence insufficiency in children? Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians. 2022;42(1):59–70. - PMC - PubMed
Publication types
Grants and funding
- U10 EY022594/EY/NEI NIH HHS/United States
- U10 EY014709/EY/NEI NIH HHS/United States
- U10 EY022592/EY/NEI NIH HHS/United States
- U10 EY022586/EY/NEI NIH HHS/United States
- U10 EY022601/EY/NEI NIH HHS/United States
- U10 EY022591/EY/NEI NIH HHS/United States
- U10 EY022596/EY/NEI NIH HHS/United States
- U10 EY014710/EY/NEI NIH HHS/United States
- U10 EY014716/EY/NEI NIH HHS/United States
- U10 EY014659/EY/NEI NIH HHS/United States
- U10 EY014712/EY/NEI NIH HHS/United States
- U10 EY022587/EY/NEI NIH HHS/United States
- U10 EY014676/EY/NEI NIH HHS/United States
- U10 EY014706/EY/NEI NIH HHS/United States
- U10 EY014713/EY/NEI NIH HHS/United States
- U10 EY022599/EY/NEI NIH HHS/United States
- U10 EY014715/EY/NEI NIH HHS/United States
- U10 EY022595/EY/NEI NIH HHS/United States
- U10 EY022600/EY/NEI NIH HHS/United States
LinkOut - more resources
Full Text Sources
